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This paper provides pharmacological evidence for antimotility of apigenin and luteolin two component of Dracocephalum 
kotschyi in vivo. In addition it was revealed that inactive apigenin-4'-galactoside in the gastrointestinal tract is converted to active 
apigenin.
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Introduction: Dracocephalum kotschyi is an Iranian indigenous herbal plant which has been 
reported to have antispasmodic activity in vitro. The antispasmodic activity of hydroalcoholic 
extract of D. kotschyi is reported to be due to its flavonoids constituents including apigenin 
and luteolin. The objective of this research was to compare antispasmodic activities of 
hydroalcoholic and flavonoids extracts of D. kotschyi on ileum contractions in vivo. In addition, 
spasmolytic activity of apigenin, luteolin and apigenin-4'-galactoside were compared. 
Methods: The hydroalcoholic extract was prepared by percolation method. Flavonoids extract 
was obtained by solvent-solvent extraction. Antispasmodic effect of the test compounds was 
assessed by measurement of percent small intestine transit following oral administration of a 
charcoal meal and compared with control group and standard drug loperamide. 
Results: Biochemical assessment of flavonoids content of the extracts showed that ethyl-acetate 
fraction contained higher quantity of flavonoids. Loperamide (2.5 mg/kg) reduced charcoal 
meal movement by 58% in comparison to control group. Hydroalcoholic extract of D. kotschyi 
(20 mg/kg) and its ethyl-acetate fraction (20 mg/kg) reduced the intestinal charcoal meal transit 
by 32% and 90%, respectively. Apigenin, luteolin and apigenen-4'-galactoside with oral dose of 
20 mg/kg inhibited intestinal movement of the charcoal meal 93%, 89% and 45%, respectively 
in comparison with the vehicle treated control groups. 
Conclusion: This study confirms that both the hydroalcoholic and flavonoids extracts of D. 
kotschyi have antispasmodic properties in vivo. Antimotility of apigenen-4'-galactoside in mice 
is probably due to release of apigenin in the gastrointestinal tract.
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A B S T R A C T
Introduction 
Dracocephalum kotschyi Boiss. is a traditional Iranian 
medicinal plant belonging to Labiatae family (1). D. 
kotschyi is an aromatic plant enriched in essential 
oil including carveol, α-pinene, geraniol, α-citral, 
cyclononadiene, terpinene-4-ol, linalool, neral, myrcene, 
germacrene–D, isopinocarveol, limonene and α-terpineol 
(2-4). In recent years several reports have been published 
on pharmacological activities of D. kotschyi. For 
instance, the essential oil of D. kotschyi reported to have 
anti-inflammatory and antinociceptive activities (5). 
Hydroalcoholic extract of D. kotschyi was reported to 
have antihyperlipidemic effect in an animal model (6) 
and inhibit tumor proliferation (7-9). Hydroalcoholic 
extract of D. Kotschyi has spasmolytic activities on 
isolated ileum and uterus (10,11). In addition, D. kotschyi 
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extract has also been shown to have immunomodulatory, 
anti-inflammatory and anti-colitis properties (12,13). It 
is believed that pharmacological effect of the extract is 
mainly due to presence of flavonoids constituents (14). 
Flavonoids are widely distributed in the plant kingdom and 
occur in many medicinal plants (13,14). The flavonoids 
constituents of D. kotschyi extract include, apigenin, 
apigenin 4'-O-beta-D-glucopyranoside, luteolin, luteolin 
7-O-beta-D-glucopyranoside, luteolin 3'-O-beta-D-
glucuronide, calycopterin, xanthomicrol, isokaempferide, 
acacetin 7-O-beta-D-glucopyranoside and rosmarinic 
acid (15, 16). It has been reported that calycopterin 
is responsible for immunomodulatory effect of D. 
kotschyi (17), while apigenin was reported to have anti-
inflammatory action (18). Among flavonoids constituents 
of D. kotschyi apigenin and luteolin have potent 
antispasmodic activities in vitro (19). However, apigenin-
4'-galacotside shows no significant antispasmodic activity 
on isolated rat ileum (20). Therefore, it seems that 
aglycones forms of the flavonoids existed in the plant are 
pharmacological active constituents. Nevertheless, it is 
likely that in the gastrointestinal tract glycoside molecule 
can be removed by gut enzymes and aglycones forms of 
flavonoids could be released. Therefore, first objective of 
this research was to investigate the antimotility effect of 
D. kotschyi flavonoids rich fraction with hydroalcoholic 
extract in vivo. The second objective was to compare 
antimotility of luteolin and apigenin with that of apigenin-
4'-galactose as well as the total extracts to find out which 
have stronger antimotility activities. 
Materials and Methods
Dracocephalum kotschyi aerial parts were collected from 
a cultivated farm in Fereydun-Shahr mountain base 
(in Isfahan province, Iran) and identified at the Botany 
Department of the Faculty of Sciences, University of 
Isfahan. A voucher specimen was deposited at the 
herbarium of the School of Pharmacy and Pharmaceutical 
Sciences of Isfahan University of Medical Sciences (No. 
1519).
The plant materials were dried in shade and ground 
to powder using electrical miller (Keep, Korea). The 
powdered materials were subjected to extraction by 70% 
ethanol in a percolator apparatus. The ratio of plant powder 
to solvent for hydroalcoholic extract was 1:8. The solvent 
was evaporated under vacuum using rotary (Heidolph, 
Germany) at 70˚C and the yield of hydroalcoholic extract 
was determined. The hydroalcoholic extract (100 g) 
then was subjected to solvent-solvent extraction using 
chloroform/water mixture (1:1) and shacked thoroughly 
and the chloroform layer was decanted. Fresh chloroform 
was added and the process was repeated twice. The 
aqueous layer was then mixed with ethyl-acetate (2:1) and 
shacked as before. The ethyl-acetate layer was decanted 
and the fresh ethyl-acetate was added and the process was 
repeated five times. These fractions were concentrated 
under vacuum using rotary at 30˚C for ethyl-acetate and 
at 90˚C for the aqueous fraction (21-23). The yield of 
dried extract was calculated for each fraction. 
Biochemical standardization of the extract 
Total flavonoids content of the hydroalcoholic extract and 
other fractions were determined by aluminum chloride 
colorimetric method (24). Fifty milligrams of quercetin 
was dissolved in 50 mL methanol and then diluted to 4, 
20, 100 and 500 µg/mL. The diluted standard solutions 
(0.1 mL) were separately mixed with 0.1 mL of 20% 
aluminum chloride, 0.1 mL of glacial acetic acid and 2.7 
mL of methanol. After incubation at room temperature 
for 40 minutes in the dark, the absorbance of the reaction 
mixture was measured at 415 nm with a Jenway 5105 U.V/V 
spectrophotometer (England). The spectrophotometer 
was initially calibrated with blank solution. In the blank 
solution, aluminum chloride was substituted by the same 
amount of distilled water. The assessment was repeated 3 
times. Similarly, 0.1 mL of hydroalcoholic extract or other 
fraction solutions were reacted with aluminum chloride 
for determination of their total flavonoids content. 
Drugs and solutions
The following drugs and solutions were used in this 
research: D. kotschyi hydroalcoholic extract, aqueous and 
ethyl-acetate fractions, loperamide, apigenin, luteolin and 
apigenin-4'-galacotside. The hydroalcoholic extract was 
made up as 10 and 40 mg/mL stock solution in 50% ethanol 
and diluted in distilled water to obtain concentrations of 1, 
4 and 10 mg/mL. Aqueous and ethyl-acetate fractions were 
made up as 10 and 50 mg/mL stock solution in ethanol and 
further serial dilution was made in distilled water (1 and 
5 mg/mL). Loperamide was dissolved in ethanol as 1 mg/
mL stock solution and was further diluted with distilled 
water (100 µg/mL). Apigenin, luteolin (Aktin Chemical 
Ins. China) and apigenin-4'-galacotside was made up as 
4 and 20 mg/mL stock suspension or solution in DMSO. 
Further dilution was made in distilled water (0.2 and 
1 mg/mL in 5% DMSO, respectively). Charchol (3%) 
plus tragacanth powder (5%) suspension was prepared 
in distilled water. Unless stated, all the chemicals were 
purchased from Merck (Germany). 
Pharmacological studies
Male albino mice (20-30 g), bred in School of Pharmacy 
and Pharmaceutical Sciences (Isfahan University of 
Medical Sciences, Iran) animal house, were kept at room 
temperature. The animals were fasted overnight prior to 
the experiments with free access to water. All animals were 
handled in accordance with the internationally accepted 
principles for laboratory animal use and care (25). In 
this study effect of hydroalcoholic and aqueous and 
ethyl-acetate fractions, loperamide (2.5 mg/kg), apigenin 
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and luteolin (2.5, 5, 10 and 20 mg/kg) and apigenin-4'-
galacotside (5, 10, 20 and 40 mg/kg) were examined on gut 
motility using charcoal meal transit test. All experiments 
were conducted in parallel with control groups treated 
with equivalent volume of the vehicle. Each dose of drug 
was examined on 10 separate mice. Stock solution was 
adjusted in such way that each mouse was given 0.5 mL of 
test drugs or extracts.
Charcoal meal transit test
In this experiment, movement of charcoal meal in the 
small intestine was assessed. For this purpose D. kotschyi 
hydroalcoholic extract (5, 20, 80 and 120 mg/kg), 
flavonoids extract (5 and 20 mg/kg), apigenin and luteolin 
(2.5, 5, 10 and 20 mg/kg) and apigenin-4'-galacotside 
(5, 10, 20 and 40 mg/kg) or loperamide (2.5 mg/kg) 
was given orally to mice and 45 minutes later 0.5 mL of 
charcoal meal containing 3% charcoal plus 5% tragacanth 
suspension was administered orally. Thirty minutes after 
charcoal meal administration, each animal was sacrificed 
and distance of charcoal movement in the small intestine 
was measured. 
Measurement and statistical analysis
Ileum transit was expressed as percentage of charcoal 
moved from pylorus to the caecum relative to the whole 
length of the ileum. All results were expressed as mean 
± standard error of mean (SEM) and compared with 
corresponding vehicle-treated control group using 
unpaired Student's t test. P values less than 0.05 was 
considered statistically significant. SigmaPlot computer 
program (version 11) was used for statistical analysis and 
plotting the graphs.
Results
The yield of hydroalcoholic extract was 23% (W/W). 
Amounts of total flavonoids content were 0.36%, 0.003%, 
0.1% and 1.12% for hydroalcoholic, chloroform, aqueous 
and ethyl-acetate fractions, respectively. 
Charcoal meal transit test 
In the control group treated with distilled water, 
charcoal meal moved up to 97% of small intestine 
within 30 minutes of oral administration of charcoal 
meal. Loperamide (2.5 mg/kg), tested as a standard 
drug, reduced charcoal movement by 58% relative to the 
vehicle treated control group. There was no statistically 
significant difference between distilled water treated 
control and the control group treated with vehicle 
(ethanol) (Figure 1). Hydroalcoholic extract of D. kotschyi 
with dose of 5 mg/kg had no significant inhibitory effect 
on intestinal charcoal meal transit but with dose of 20 mg/
kg significantly reduced meal transit by 32%. When the 
dose of hydroalcoholic extract was increased to 80 mg/
kg intestinal transit was inhibited by 70% compared to 
vehicle treated control group (Figure 2). Further increase 
in dose of D. kotschyi hydroalcoholic extract (120 mg/kg) 
had no more inhibitory effect on intestinal meal transit. 
Ethyl-acetate fraction prepared from D. kotschyi extract 
had more pronounced inhibitory effect on charcoal meal 
transit compared to hydroalcoholic extract. Oral dose of 
5 mg/kg ethyl-acetate fraction reduced intestinal transit 
by 45% relative to vehicle treated control group. Ethyl-
acetate fraction of D. kotschyi with oral dose of 20 mg/
kg inhibited the charcoal meal transit by 90% (Figure 1). 
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Figure 1. Effect of loperamide and ethyl-acetate fraction of D. kotschyi 
on intestinal distance moved by charcoal meal (0.5 mL; per orum) in 
comparison with the vehicle treated control group in mice. Data are 
expressed as mean±SEM (n=10). Stars show degree of statistically 
significant difference in comparison with its appropriate control group 
(*P<0.05, ***P<0.001, Student's t test).
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Figure 2. Effect of hydroalcoholic extract of D. kotschyi on intestinal 
distance moved by charcoal meal (0.5 mL; per orum) in comparison 
with the vehicle treated control group in mice. Data are expressed 
as mean±SEM (n=10). Stars show degree of statistically significant 
difference in comparison with its appropriate control group (***P<0.001, 
Student's t test). 
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Remaining aqueous fraction up to dose of 120 mg/kg 
exhibited no inhibitory effect on intestinal charcoal meal 
transit (Figure 3). 
Luteolin and apigenin are two known flavonoids which 
have been identified in D. kotschyi extract. Both these 
flavonoids components in a dose dependent manner 
inhibited mice intestinal motility. Luteolin and apigenin 
at oral dose of 2.5 mg/kg reduced intestinal charcoal meal 
transit by 40% and 42%, respectively compared to vehicle 
treated control group (Figures 4 & 5). With oral dose of 
20 mg/kg, movement of transit meal was inhibited by 89% 
and 93%, respectively. Apigenin-4'-galacotside with oral 
dose of 5 mg/kg had no significant effect on charcoal meal 
transit. However, with higher doses (10, 20 and 40 mg/kg) 
significantly inhibited intestinal transit by 38%, 45% and 
55%, respectively (Figure 6). In the control groups treated 
with vehicle (DMSO) there were no statistically significant 
differences compared with distilled water treated group.
Discussion
Hydroalcoholic extract of D. kotschyi possessed 
spasmolytic activity on isolated rat ileum and uterus 
(10,11). In addition, D. kotschyi extract has been shown 
to reduce diarrhea induced in mice (26). Furthermore, 
it has been shown to have anti-colitis activity in animal 
model of colitis (12). Antispasmodic activity of D. kotschyi 
extract has been attributed to its flavonoids contents 
including luteolin and apigenin (20). In this research we 
have focused on antispasmodic action of hydroalcoholic 
and flavonoids extracts of D. kotschyi in whole animal to 
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Figure 3. Effect of aqueous fraction of D. kotschyi on intestinal 
distance moved by charcoal meal (0.5 mL; per orum) in comparison 
with the vehicle treated control group in mice. Data are expressed 
as mean±SEM (n=10). There is no statistically significant difference 
between test and control groups. 
Figure 5. Effect of apigenin on intestinal distance moved by charcoal 
meal (0.5 mL; per orum) in comparison with the vehicle treated control 
group in mice. Data are expressed as mean±SEM (n=10). Stars show 
degree of statistically significant difference in comparison with its 
appropriate control group (**P<0.05, ***P<0.001, Student's t test).
Figure 4. Effect of luteolin on intestinal distance moved by charcoal 
meal (0.5 mL; per orum) in comparison with the vehicle treated control 
group in mice. Data are expressed as mean±SEM (n=10). Stars show 
degree of statistically significant difference in comparison with its 
appropriate control group (***P<0.001, Student's t test).
Figure 6. Effect of apigenin-4'-galactoside on intestinal distance moved 
by charcoal meal (0.5ml; per orum) in comparison with the vehicle treated 
control group in mice. Data are expressed as mean±SEM (n=10). Stars 
show degree of statistically significant difference in comparison with its 
appropriate control group (***P<0.001, Student's t test). 
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Figure 4: Effect of luteolin on intestinal distance moved by charcoal meal (0.5ml; per orum) in 
comparison with the vehicle treated control group in mice. Data are expressed as meanSEM (n=10). 
Stars show degree of statistically significant difference in comparison with its appropriate control 
group (***P<0.001, Student's t-test). 
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find out which one would be more suitable remedy for 
gastrointestinal aliments. Furthermore, antispasmodic 
actions of three components of D. kotschyi extract were 
also assessed in vivo. 
Hydroalcoholic extract contains both polar and non-
polar constituents while the chloroform fraction mainly 
contains non-polar constituents including non-active 
substances such as chlorophyll. In the mixture of water 
and ethyl-acetate, polar substances would be dissolves 
in the aqueous part while less polar substances including 
flavonoids are dissolved in ethyl-acetate layer. Biochemical 
assay also confirm that ethyl-acetate fraction is enrich 
in flavonoids. Inhibition of small intestine transit also 
confirms that more active substances are concentrated 
in the flavonoids rich fraction. Measurement of transit of 
meal in the small intestine has been used for assessment 
of gut motility in intact animal. It has been shown that 
hydroalcoholic extract of D. kotschyi with oral doses of 20 
and 80 mg/kg caused significant inhibition of intestinal 
motility. Furthermore, increase in dose had no further 
inhibitory effect indicating that it is possible that other 
components presence in the extract cause its inhibitory 
action. As mentioned above most of flavonoids components 
are concentrated in the ethyl-acetate fraction. Ethyl-acetate 
fraction with dose of 20 mg/kg reduced intestinal motility 
by 90% while hydroalcoholic extract reduced by 32%. 
This indicates that flavonoids extract is pharmacologically 
more active than the hydroalcoholic extract. Luteolin and 
apigenin are two flavonoids component of D. kotschyi 
with antimotility activities. Therefore, it can be concluded 
that they have major contribution in the antispasmodic 
activity of D. kotschyi extract. Comparison of antimotility 
of luteolin and apigenin with similar doses indicates that 
they have similar pharmacological activities on intestinal 
meal transit. On the other hand, apigenin-4'-galacotside 
was less active in comparison to apigenin. However, unlike 
rat isolated ileum (20), apigenin-4'-galacotside inhibited 
gut motility in vivo which is a good indication that in the 
gastrointestinal tract, the galactoside molecule is removed 
and aglycone apigenin is released. Therefore, it is very 
likely that the observed inhibitory effect of apigenin-4'-
galacotside is due to action of apigenin. 
Conclusion
In conclusion this study clearly shows the antimotility 
effect of D. kotschyi extract in intact animal and indicates 
that antispasmodic effect of extract is mainly due to its 
flavonoids contents including apigenin and luteolin. 
As galactoside form of apigenin and luteolin lack 
antispasmodic activity in vitro, this study indicates that in 
the gastrointestinal tract, the sugar moiety is removed and 
active aglycones flavonoids are released. 
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